Gilead Sciences
Latest statistics and disclosures from Gilead Sciences's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RCUS, GLPG, ACLX, ASMB, KYTX, and represent 99.70% of Gilead Sciences's stock portfolio.
- Reduced shares in these 3 stocks: MRUS (-$43M), TNGX (-$41M), CYPH.
- Sold out of its positions in CYPH, TNGX, MRUS.
- Gilead Sciences was a net seller of stock by $-86M.
- Gilead Sciences has $1.9B in assets under management (AUM), dropping by 8.04%.
- Central Index Key (CIK): 0000882095
Tip: Access up to 7 years of quarterly data
Positions held by Gilead Sciences consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcus Biosciences Incorporated (RCUS) | 38.7 | $749M | 31M | 23.83 |
|
|
| Galapagos Nv Spon Adr (GLPG) | 28.4 | $551M | 17M | 32.96 |
|
|
| Arcellx Common Stock (ACLX) | 22.6 | $438M | 6.7M | 65.20 |
|
|
| Assembly Biosciences Com New (ASMB) | 7.9 | $153M | 4.5M | 34.01 |
|
|
| Kyverna Therapeutics (KYTX) | 2.0 | $39M | 4.1M | 9.40 |
|
|
| Xilio Therapeutics (XLO) | 0.3 | $5.8M | 9.1M | 0.64 |
|
Past Filings by Gilead Sciences
SEC 13F filings are viewable for Gilead Sciences going back to 2024
- Gilead Sciences 2025 Q4 filed Feb. 12, 2026
- Gilead Sciences 2025 Q3 filed Nov. 13, 2025
- Gilead Sciences 2025 Q2 filed Aug. 14, 2025
- Gilead Sciences 2025 Q1 filed May 13, 2025
- Gilead Sciences 2024 Q4 filed Feb. 13, 2025